OakChart

Novavax Inc

NVAXHealthcare·Biotechnology·USA·Small·NASD·Nov 11 • 3:59 PM ET

9.98-0.22 (-2.16%)
2026-11-12 06:16 CET
Market cap
1,646.79 USD m
Revenue, TTM
411.65 USD m
Net income, TTM
-76.73 USD m
Free cash flow, TTM
-243.90 USD m
EPS diluted, TTM
-0.47
P/E
-
Compare

Price

NVAX against its 20, 50 and 200-day averages
2050200beat
8.0010.0012.0014.3M28.7MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26NVAXclose 9.9820-day 10.4450-day 10.60200-day 9.349.9852w high

25.4% under the 52-week high of 13.39 on 5 Oct 2026. 52-week low 6.20 on 20 Nov 2025. Last 15 sessions, 25.1% high to low

Volume 0.89× normal · the line is the 50-bar volume average

Profile

NVAX
52-week range, 53% of the way up
6.2013.39

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

IndexRUT
Employees749
IPODec 05, 1995
Beta2.71
ATR, 14d0.86
Rel volume0.89
Short float29.55%
Insider own4.97%
Inst own63.45%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap1.65B
Enterprise Value1.32B
Income-76.73M
Sales411.65M
Book/sh-1.31
Cash/sh3.77
Dividend Est.-
Dividend TTM-
Dividend Ex-DateDec 13, 2007
Dividend Gr. 3/5Y- -
Payout0.00%
Employees749
IPODec 05, 1995

Ratios

P/E-
Forward P/E-
PEG-
P/S4.00
P/B-
P/C2.65
P/FCF-
EV/EBITDA-
EV/Sales3.21
Quick Ratio2.09
Current Ratio2.15
Debt/Eq-
LT Debt/Eq-
Option/ShortYes / Yes

Earnings

EPS (ttm)-0.47
EPS next Y-0.45
EPS next Q0.54
EPS this Y-102.00%
EPS next Y-763.03%
EPS next 5Y-
EPS past 3/5Y- -
Sales past 3/5Y-17.24% 18.76%
EPS Y/Y TTM-121.87%
Sales Y/Y TTM-61.33%
EPS Q/Q84.74%
Sales Q/Q-3.05%
EarningsNov 05 BMO
EPS/Sales Surpr.45.09% 35.45%

Ownership

Insider Own4.97%
Insider Trans0.00%
Inst Own63.45%
Inst Trans-0.64%
ROA-7.42%
ROE-
ROIC-99.96%
Gross Margin78.54%
Oper. Margin-16.53%
Profit Margin-18.64%
SMA20-4.41%
SMA50-5.89%
SMA2006.84%
Trades-

Technical

Shs Outstand164.99M
Shs Float156.81M
Short Float29.55%
Short Ratio6.99
Short Interest46.33M
52W High13.39 -25.44%
52W Low6.20 60.97%
Volatility8.33% 8.34%
ATR (14)0.86
RSI (14)46.20
Beta2.71
Rel Volume0.89
Avg Volume6.62M
Volume5,896,001

Performance

Perf Week-6.29%
Perf Month-22.15%
Perf Quarter22.60%
Perf Half Y8.13%
Perf YTD48.51%
Perf Year34.14%
Perf 3Y59.94%
Perf 5Y-94.11%
Perf 10Y-64.10%
Recom2.62
Target Price13.88
Prev Close10.20
Price9.98
Change %-2.16%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Oct 24, 2025ResumedCCantor FitzgeraldOverweight$18+80.4%
Aug 28, 2025ResumedHH.C. WainwrightBuy$10+0.2%
Aug 20, 2025DowngradeBBofA SecuritiesNeutral → Underperform$7-29.9%
Jun 17, 2025InitiatedCCitigroupSell$6-39.9%
Feb 28, 2025InitiatedBBTIG ResearchBuy$19+90.4%
Jul 30, 2024DowngradeJJP MorganNeutral → Underweight$8-19.8%
May 10, 2024UpgradeJJP MorganUnderweight → Neutral
May 10, 2024UpgradeBBofA SecuritiesUnderperform → Neutral$4 → $12+20.2%
Aug 09, 2023UpgradeRB. Riley SecuritiesNeutral → Buy$15+50.3%
Apr 20, 2023DowngradeTTD CowenOutperform → Market Perform$55 → $10+0.2%

Peers

Mkt cap
TickerCompanyMkt cap
MRNAModerna Inc100.63B
BNTXBioNTech SE ADR21.73B
ARCTArcturus Therapeutics Holdings Inc268.33M
VALNValneva SE ADR563.17M
PCVXVaxcyte Inc10.86B
PFEPfizer Inc167.86B
SNYSanofi ADR115.43B
VIRVir Biotechnology Inc2.25B
GSKGSK Plc ADR101.43B
EBSEmergent Biosolutions Inc310.55M

Insider trading

latest 14 of 16
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Ruxandra Draghia AkliFormer OfficerMay 27 '26Proposed Sale11.0121,383235,412May 27 04:42 PM
Ruxandra Draghia AkliFormer OfficerMay 07 '26Proposed Sale9.8730,000296,083May 07 05:03 PM
Newton Charles W.DirectorApr 25 '26Option Exercise0.009,52009,520Apr 28 05:00 PM
Shiver John W.DirectorMar 10 '26Option Exercise0.007,94707,947Mar 12 05:00 PM
Kelly James PatrickEVP, CFO and TreasurerMar 07 '26Option Exercise0.0012,2230136,503Mar 09 06:13 PM
Kelly James PatrickEVP, CFO and TreasurerMar 03 '26Option Exercise0.0043,1670145,130Mar 05 06:04 AM
Jacobs John CPresident and CEOMar 03 '26Option Exercise0.00150,1670264,130Mar 05 06:03 AM
O'Hara ElaineEVP, Chief Strategy OfficerMar 03 '26Option Exercise0.0056,3340157,071Mar 05 06:02 AM
Casey Mark JEVP, Chief Legal OfficerMar 03 '26Option Exercise0.0037,5000101,445Mar 05 06:01 AM
Draghia-Akli RuxandraEVP, Research & DevelopmentMar 03 '26Option Exercise0.0026,667034,876Mar 05 06:00 AM
Jacobs John CPresident and CEOMar 01 '26Option Exercise0.0083,3330264,130Mar 03 09:37 PM
Kelly James PatrickEVP, CFO and TreasurerMar 01 '26Option Exercise0.0058,6660130,299Mar 03 09:35 PM
O'Hara ElaineEVP, Chief Strategy OfficerMar 01 '26Option Exercise0.0059,6000111,706Mar 03 09:34 PM
Casey Mark JEVP, Chief Legal OfficerMar 01 '26Option Exercise0.004,000065,159Mar 03 09:33 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
XBIState Street SPDR S&P Biotech ETFAUM: 10.50B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
VBKVanguard Morningstar Small-Cap Growth ETFAUM: 22.34B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWNiShares Russell 2000 Value ETFAUM: 14.10B
PBEInvesco Biotechnology & Genome ETFAUM: 438.02M
IBBiShares Biotechnology ETFAUM: 11.36B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-05-0.190-0.346-0.19068.3050.427
2026Q22026-08-06-0.320-0.380-0.32456.7052.517
2026Q12026-05-06-0.060-0.242-0.058139.5179.817
2025Q42026-02-260.110-0.4850.106147.1489.858
2025Q32025-11-06-1.250-1.196-1.24770.4542.137
2025Q22025-08-060.6200.0080.601239.24152.616
2025Q12025-05-082.930-0.4232.920666.66343.853
2024Q42025-02-27-0.510-0.514-0.50688.3184.385
2024Q32024-11-12-0.760-0.791-0.75884.5173.785
2024Q22024-08-080.9901.6700.995415.48458.584
2024Q12024-05-10-1.050-1.064-1.05593.86101.165
2023Q42024-02-28-1.440-0.448-1.442291.34322.056
2023Q32023-11-09-1.260-2.215-1.264186.99115.426
2023Q22023-08-080.580-1.3320.582424.43264.166
2023Q12023-05-09-3.410-3.462-3.41180.9587.615
2022Q42023-02-28-2.280-1.014-2.283357.4383.145

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-5.510-5.436-5.50618.6611.90
2020FY-7.270-5.807-7.267475.6446.35
2021FY-23.440-13.702-23.4381,1461,263
2022FY-8.420-7.164-8.4151,9822,008
2023FY-5.410-4.222-5.409983.711,014
2024FY-1.230-1.325-1.232682.16684.94
2025FY2.5802.2342.5801,1001,064
2026FY--0.052--473.1
2027FY--0.446--246.08
2028FY--0.065--209.37
2029FY-1.213--484.04
2030FY-0.970--444.13

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-09870216143.09315.9
2026Q4S2026-11-06870215.98143.09315.9
2026Q4S2026-11-05770196.1143.09251.44
2026Q4S2026-10-27740123.2133.09199.9
2026Q4S2026-10-23730115.3133.09192.31
2026Q4S2026-10-20720105.5933.09175.75
2026Q4S2026-10-15742105.5933.09175.75
2026Q4S2026-10-14742105.7833.09175.75
2026Q4S2026-10-09743105.7833.09175.75
2026Q4S2026-10-0573497.2233.09154.02
2026Q4S2026-08-0772593.8233.09154.02
2026Q4S2026-08-06724105.4133.09196.97
2026Q4S2026-07-31701100.1142.30196.97
2026Q4S2026-07-29700131.0442.30361.1

Estimate history

EPS, annual-12.6-9.993-5.506-7.267-23.438-8.415-5.409-1.2322.544-0.4667
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.758-0.5062.920.601-1.2470.106-0.058-0.324-0.19
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual31.17634.28818.662475.5981146.291981.872983.705682.1621123.479411.65
Period201720182019202020212022202320242025TTM
Sales, quarterly84.51288.311666.655239.2470.445147.139139.51456.69868.298
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual16.16119.22332.35270.95475.84186.04139.506160.421162.576164.993
Period201720182019202020212022202320242025MRQ
Shares, quarterly160.148160.421161.958162.155162.47162.576164.423164.816164.993
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue411.651,123.48682.16983.711,981.871,146.29475.6018.6634.29
Cost of Goods Sold Incl. D&A88.3371.14197.94279.47902.6412.66---
Gross Profit323.321,052.34484.22704.241,079.231,133.63---
Selling, General and Administrative Excl. Other386.04487.17712.391,113.161,723.972,820.20884.73142.46200.05
Research and Development287.08336.82388.77656.001,235.282,534.51747.03113.84173.80
Other Operating Expense5.301.903.806.100.000.000.000.000.00
Operating Income-68.03563.27-231.97-415.03-644.74-1,686.58-414.02-129.60-173.92
Interest Expense21.8222.5520.0714.4219.8821.1315.1413.6113.61
Unusual Expense19.36139.1916.96151.480.000.002.70--
Net Income Before Taxes-71.93442.17-176.62-543.03-653.65-1,714.54-418.26-132.69-184.75
Income Taxes4.791.8610.882.034.2929.210.000.000.00
Consolidated Net Income-76.73440.30-187.50-545.06-657.94-1,743.75-418.26-132.69-184.75
Net Income From Continuing Operations-76.73440.30-187.50-545.06-657.94-1,743.75-418.26-132.69-184.75
Net Income-76.73440.30-187.50-545.06-657.94-1,743.75-418.26-132.69-184.75
EPS (Recurring)-0.403.11-1.15-4.36-8.42-23.44-7.23-5.51-9.99
EPS (Basic, Before Extraordinaries)-0.462.72-1.23-5.41-8.42-23.44-7.27-5.51-9.99
EPS (Diluted)-0.472.54-1.23-5.41-8.42-23.44-7.27-5.51-9.99
EBITDA-53.74590.88-183.47-373.80-615.68-1,673.91-409.13-123.80-165.76
Non-Operating Income (Expense)37.2740.6392.3937.9010.97-6.8313.6110.522.78
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense25.0728.4538.0467.43102.94183.63128.0317.0518.31
Price To Sales Ratio4.331.041.790.490.419.2913.495.1419.84
Gross Margin78.5493.6770.9871.5954.4698.90---
Operating Margin-16.5350.14-34.01-42.19-32.53-147.13-87.05-694.44-507.23
Net Margin-18.6439.19-27.49-55.41-33.20-152.12-87.94-711.04-538.81
Shares Outstanding164.99162.58160.42139.5186.0475.8470.9532.3519.22
Market Capitalization1,646.791,646.791,287.89570.19873.8410,817.257,098.72105.78707.39

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue68.3056.70139.51147.1470.44239.24666.6588.31
Cost of Goods Sold Incl. D&A19.7912.6530.7025.2019.8014.2213.8152.27
Gross Profit48.5144.05108.82121.9450.65225.01652.8436.04
Selling, General and Administrative Excl. Other72.9893.26118.89100.92129.85118.25136.52177.69
Research and Development49.8467.7995.4773.9898.1777.6388.94104.28
Other Operating Expense3.701.600.000.000.201.100.30-16.10
Operating Income-28.17-50.81-10.0721.02-79.40105.67516.02-125.55
Interest Expense5.405.694.905.825.485.525.727.58
Unusual Expense3.114.105.366.79127.334.600.515.53
Net Income Before Taxes-29.65-51.68-8.5117.90-203.04107.45519.85-73.58
Income Taxes1.721.710.980.38-0.660.951.207.45
Consolidated Net Income-31.38-53.39-9.4917.53-202.38106.51518.65-81.03
Net Income From Continuing Operations-31.38-53.39-9.4917.53-202.38106.51518.65-81.03
Net Income-31.38-53.39-9.4917.53-202.38106.51518.65-81.03
EPS (Recurring)-0.18-0.31-0.040.12-0.700.622.92-0.48
EPS (Basic, Before Extraordinaries)-0.19-0.32-0.060.11-1.250.663.22-0.51
EPS (Diluted)-0.19-0.32-0.060.11-1.250.602.92-0.51
EBITDA-25.13-47.75-7.0126.14-72.82113.23524.36-113.04
Non-Operating Income (Expense)7.038.9211.829.509.1811.9010.0665.08
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense6.286.396.106.296.757.288.138.25
Price To Earnings Ratio--3.423.803.842.38--
Price To Sales Ratio4.333.752.230.991.321.030.911.89
Gross Margin71.0377.7078.0082.8771.9094.0597.9340.81
Operating Margin-41.25-89.61-7.2214.29-112.7244.1777.40-142.17
Net Margin-45.94-94.16-6.8011.91-287.2944.5277.80-91.76
Shares Outstanding164.99164.82164.42162.58162.47162.16161.96160.42
Market Capitalization1,646.791,549.011,326.301,091.991,408.201,020.411,031.011,287.89

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments745.96933.74578.931,347.191,526.61804.9381.77102.98185.54
Short Term Receivables106.45108.28297.2482.38454.99262.017.500.000.00
Inventories11.548.7541.7036.680.000.000.000.000.00
Other Current Assets114.3378.16226.02237.15173.52181.267.9816.3017.77
Total Current Assets978.281,128.941,143.891,703.392,155.121,248.2097.25119.28203.31
Net Property, Plant & Equipment67.70300.00490.99400.49268.82187.7517.9028.4335.99
Total Investments and Advances4.544.444.881.661.651.460.410.960.89
Intangible Assets113.46107.48127.45126.33136.25141.1056.7358.5161.44
Deferred Tax Assets6.2942.2557.85------
Other Assets12.5419.5630.2826.8114.913.960.670.810.87
Total Assets1,182.801,602.671,855.342,258.682,576.751,582.48172.96207.98302.49
Short Term Debt Incl. Current Port. of LT Debt12.3817.1028.12368.94161.52109.641.260.000.00
Accounts Payable24.5841.58132.61216.52127.0554.332.919.305.61
Other Current Liabilities422.991,095.731,474.411,874.482,101.75415.7021.6236.2468.06
Total Current Liabilities459.951,154.421,635.142,459.942,390.32579.6725.8045.5473.67
Long Term Debt265.66246.37252.52247.79362.57372.24330.62319.19317.76
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities5.8342.6559.90------
Other Liabilities579.11783.07624.72185.02175.533.362.5611.1912.79
Total Liabilities1,310.552,226.512,572.272,892.762,928.43955.27358.97375.91404.23
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity-127.75-623.84-716.93-634.08-351.67627.21-186.02-167.94-101.73
Total Shareholders Equity-127.75-623.84-716.93-634.08-351.67627.21-186.02-167.94-101.73
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity-127.75-623.84-716.93-634.08-351.67627.21-186.02-167.94-101.73
Total Liabilities & Stockholders Equity1,182.801,602.671,855.342,258.682,576.751,582.48172.96207.98302.49
Book Value Per Share-0.79-3.89-5.14-7.37-4.648.84-5.75-8.74-6.29
Tangible Book Value Per Share-1.48-4.56-6.05-8.84-6.436.85-7.50-11.78-10.10
Full-Time Employees7499521,5431,9921,541791165379347
Price to Book Ratio-7.59-2.45-0.84-1.43-30.8512.61-0.69-4.21-5.19
Return on Assets31.61-10.84-26.50-27.21-83.85-47.65-69.67-72.38-52.75
Return on Equity-----1,265.72-189.60---
Return on Invested Capital319.27----15,996.25-41.85-91.77-122.15-85.07
Quick Ratio2.100.970.670.680.902.153.772.622.76
Current Ratio2.130.980.700.690.902.153.772.622.76

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-76.73440.30-187.50-545.06-657.94-1,743.75-418.26-132.69-184.75
Depreciation14.2927.6148.5041.2329.0512.664.885.688.16
Other Funds (Non Cash)28.50175.163.26163.12574.10320.42358.8214.4112.91
Funds from Operations-33.94643.07-135.75-340.72-54.79-1,410.67-54.56-112.61-163.68
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-205.01-887.7148.48-376.84-361.151,733.6212.02-24.02-21.14
Cash from Operating Activities-238.95-244.63-87.26-717.56-415.94322.95-42.54-136.62-184.82
Capital Expenditures-4.96-6.39-14.64-58.81-92.98-57.49-54.62-1.86-1.37
Net Assets From Acquisitions0.000.000.000.000.000.00-165.520.00-
Sale of Fixed Assets and Businesses0.000.00192.640.000.000.000.0018.33-
Purchase or Sale of Investments100.52-91.53-382.040.000.00157.64-157.6422.0229.97
Purchase of Investments-391.35-445.27-825.590.000.00-2.17-363.20-17.48-120.15
Sale Or Maturity of Investments491.88353.74443.550.000.00159.81205.5639.50150.12
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources59.4019.650.000.000.000.000.000.000.00
Cash from Investing Activities154.80-78.27-204.04-58.81-92.98100.15-377.7838.4928.60
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock-6.11-4.80264.58360.40248.59589.621,080.8398.38102.81
Repurchase of Common Pref Stock-6.11-4.800.000.000.000.00-39.090.000.00
Sale of Common Pref Stock0.000.00264.58360.40248.59589.621,119.9198.38102.81
Proceedsfrom Stock Options0.000.00263.27360.24249.23564.861,075.4497.39100.06
Issuance or Reduction of Debt, Net36.3832.53-3.99-352.3576.40-127.91-96.060.000.00
Change in Long Term Debt36.3832.53-3.99-352.3576.40-127.91-96.060.000.00
Issuance of Long Term Debt46.4142.610.000.00169.990.000.000.000.00
Reduction of Long Term Debt-10.03-10.07-3.99-352.35-93.59-127.91-96.060.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.000.000.000.00
Cash from Financing Activities30.2727.74260.588.06324.99461.71984.7698.38102.81
Exchange Rate Effect-2.425.92-7.803.274.52-5.292.12-0.03-0.05
Net Change in Cash-56.30-289.24-38.52-765.03-179.41879.52566.560.22-53.47
Free Cash Flow-243.90-250.19-100.32-771.33-504.99265.46-97.16-138.48-186.20
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow-----40.10---
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments622.36719.34790.33745.96773.71623.05
Short Term Receivables49.1618.7423.31106.4534.17226.40
Inventories18.5010.0111.4611.5413.5110.24
Other Current Assets17.9323.0125.71114.33153.1959.82
Total Current Assets707.96771.10850.82978.28974.59919.51
Net Property, Plant & Equipment54.5857.9863.5167.7072.99282.69
Total Investments and Advances4.604.584.564.544.524.49
Intangible Assets112.08112.54112.89113.46113.08112.96
Deferred Tax Assets---6.29--
Other Assets8.799.3811.3912.5414.7116.90
Total Assets888.00955.581,043.161,182.801,179.891,336.55
Short Term Debt Incl. Current Port. of LT Debt1.654.112.1112.385.045.55
Accounts Payable24.9422.9416.1024.5815.2350.59
Other Current Liabilities303.25303.53324.25422.99409.61332.99
Total Current Liabilities329.85330.57342.46459.95429.87389.14
Long Term Debt293.61293.21292.95265.66246.10222.94
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities---5.83--
Other Liabilities481.40522.50552.52579.11660.59686.85
Total Liabilities1,104.861,146.281,187.921,310.551,336.561,298.92
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity-216.85-190.71-144.76-127.75-156.6737.62
Total Shareholders Equity-216.85-190.71-144.76-127.75-156.6737.62
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity-216.85-190.71-144.76-127.75-156.6737.62
Total Liabilities & Stockholders Equity888.00955.581,043.161,182.801,179.891,336.55
Book Value Per Share-1.31-1.16-0.88-0.79-0.960.23
Tangible Book Value Per Share-1.99-1.84-1.57-1.48-1.66-0.46
Full-Time Employees---749--
Price to Book Ratio-7.59-10.70-10.36-6.9737.37-13.49
Return on Assets-7.42-21.62-7.5231.6123.6326.80
Return on Invested Capital-40.88-52.08-6.4012.71-226.2940.88
Quick Ratio2.092.302.452.102.242.34
Current Ratio2.152.332.482.132.272.36

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-31.38-53.39-9.4917.53-202.38106.51
Depreciation3.053.063.065.126.587.56
Other Funds (Non Cash)7.1310.77-0.9811.57137.67-1.20
Funds from Operations-21.20-39.56-7.4134.23-58.12112.87
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-73.04-33.25-25.01-73.70165.93-240.33
Cash from Operating Activities-94.24-72.81-32.42-39.48107.80-127.46
Capital Expenditures-1.02-0.59-1.27-2.25-2.02-0.53
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments128.8035.48-66.843.08-134.51111.62
Purchase of Investments0.00-81.69-214.13-95.53-235.010.00
Sale Or Maturity of Investments128.80117.17147.2998.61100.50111.62
Other Uses0.000.000.000.000.000.00
Other Sources0.000.0039.7519.650.000.00
Cash from Investing Activities127.7834.90-28.3620.48-136.53111.10
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.661.73-8.16-0.330.82-0.43
Repurchase of Common Pref Stock0.661.73-8.16-0.330.82-0.43
Sale of Common Pref Stock0.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-2.65-0.5345.83-6.2741.62-0.61
Change in Long Term Debt-2.65-0.5345.83-6.2741.62-0.61
Issuance of Long Term Debt0.000.0046.410.0042.610.00
Reduction of Long Term Debt-2.65-0.53-0.58-6.27-0.98-0.61
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities-2.001.2037.67-6.6042.44-1.04
Exchange Rate Effect-0.52-0.18-0.02-1.710.667.91
Net Change in Cash31.02-36.88-23.13-27.3014.38-9.50
Free Cash Flow-95.26-73.39-33.69-41.55105.79-127.71

Revenue breakdown

Licensing, Royalties, and Other2024: 468.96M 2025: 438.44M
Product2024: 213.20M 2025: 685.04M
Europe2024: 96.14M 2025: 15.74M
Rest of North America2024: 4.46M 2025: 575.67M
Rest of the World2024: 59.02M 2025: 126.46M
United States2024: 522.54M 2025: 405.61M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3029.55%46.3M156.8M6.28M
2026-10-1530.20%47.3M156.8M5.70M
2026-09-3029.38%46.0M156.7M4.49M
2026-09-1531.82%49.9M156.7M4.34M
2026-08-3131.12%48.8M156.7M4.15M
2026-08-1430.31%47.5M156.7M4.13M
2026-07-3129.13%45.7M156.7M4.78M
2026-07-1528.06%43.8M156.2M4.84M
2026-06-3029.33%45.8M156.2M4.74M
2026-06-1528.89%45.1M156.1M4.59M
2026-05-2929.44%46.0M156.1M4.62M
2026-05-1529.00%45.3M156.1M4.65M
2026-04-3031.65%49.5M156.3M4.06M
2026-04-1529.91%46.3M154.9M4.90M
2026-03-3128.99%45.0M155.2M5.21M
2026-03-1331.33%48.6M155.2M5.00M
2026-02-2732.81%50.9M155.2M4.74M
2026-02-1332.86%50.9M154.8M4.45M
2026-01-3033.06%51.2M154.8M4.62M
2026-01-1534.40%53.3M154.9M3.95M

Option chain

expiry 2026-11-13
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call1.007.1011.108.970.00014.0080.000.998-0.0210.000
call2.006.1010.108.070.00022.0080.000.996-0.0210.000
call3.005.108.806.9933.71817.005.000.995-0.0210.000
call4.004.108.106.0328.40427.009.000.993-0.0210.000
call5.003.107.105.1122.4938.0012.000.991-0.0210.000
call5.503.905.104.5010.38411.004.000.990-0.0200.000
call6.003.304.704.007.1564.004.000.989-0.0200.000
call6.502.724.303.496.3025.005.000.987-0.0190.000
call7.001.304.953.176.1303.004.000.984-0.0190.000
call7.500.704.602.5412.1377.0020.000.969-0.0310.000
call8.001.072.942.107.0908.0020.000.963-0.0290.001
call8.500.003.601.568.2358.0010.000.953-0.0270.001
call9.000.801.781.114.5981171.000.896-0.0430.001
call9.500.161.010.512.7071242.000.707-0.0940.002
call10.000.050.290.291.0582361380.516-0.1220.003
call10.500.020.150.121.20821622.000.302-0.0860.002
call11.000.010.080.011.3442,1391,5990.166-0.0650.002
call11.500.020.050.041.5137125250.103-0.0520.001
call12.000.000.020.021.5051,0915510.047-0.0290.001
call12.500.000.070.011.7656211.000.041-0.0300.001
call13.000.000.010.012.0079745.000.037-0.0310.001
call13.500.000.750.032.23540.000.000.034-0.0320.001
call14.000.000.750.012.4511020.000.031-0.0330.001
call14.500.000.010.011.83711.000.000.018-0.0130.000
call15.000.002.130.022.57777.000.000.016-0.0200.000
call15.500.002.131.092.7491.001.000.015-0.0210.000
call16.000.002.131.052.9144.002.000.015-0.0210.000
call16.500.002.130.003.0740.000.000.014-0.0210.000
call17.000.002.130.543.2270.002.000.013-0.0210.000
call17.500.002.130.003.3740.000.000.013-0.0220.000
call18.000.002.131.053.5160.002.000.013-0.0220.000
call18.500.002.130.003.6530.000.000.012-0.0220.000
call19.000.002.131.053.7851.001.000.012-0.0220.000
call19.500.002.130.003.9130.000.000.011-0.0230.000
call20.000.002.130.404.0376.000.000.011-0.0230.000
call20.500.002.130.004.1570.000.000.011-0.0230.000
call21.000.002.131.034.2744.000.000.011-0.0230.000
call22.000.002.130.014.49810.000.000.010-0.0240.000
call23.000.002.131.054.7101.000.000.010-0.0240.000
call24.000.002.130.014.9101.000.000.009-0.0240.000
call25.000.002.130.425.1021.000.000.009-0.0240.000
call26.000.002.130.005.2840.000.000.009-0.0250.000
put1.000.000.010.0413.3536.001.00-0.002-0.0190.000
put2.000.002.130.099.7544.001.00-0.004-0.0210.000
put3.000.002.130.017.3573.000.00-0.005-0.0210.000
put4.000.002.130.085.68313.000.00-0.007-0.0210.000
put5.000.002.130.094.3905.000.00-0.009-0.0200.000
put5.500.002.130.013.83710.000.00-0.010-0.0200.000
put6.000.000.010.013.5355.000.00-0.019-0.0290.000
put6.500.000.010.662.7960.000.00-0.013-0.0180.000
put7.000.000.010.012.6491.000.00-0.026-0.0300.000
put7.500.000.020.732.20222.000.00-0.031-0.0290.000
put8.000.000.020.021.77937.007.00-0.037-0.0270.001
put8.500.000.020.011.37243.0020.00-0.047-0.0250.001
put9.000.010.040.031.17113418.00-0.104-0.0420.001
put9.500.030.090.080.95913243.00-0.293-0.0930.002
put10.000.020.610.312.13031280.00-0.484-0.1210.003
put10.500.160.730.591.4577322.00-0.698-0.0840.002
put11.000.691.511.113.0841205.00-0.834-0.0630.002
put11.500.293.601.628.4324.000.00-0.897-0.0510.001
put12.001.524.102.047.16185.0015.00-0.953-0.0270.001
put12.501.703.352.584.62612.0011.00-0.959-0.0290.001
put13.000.914.902.9310.0048.001.00-0.963-0.0300.001
put13.501.415.403.0010.4025.000.00-0.966-0.0310.001
put14.001.915.903.8810.7811.001.00-0.969-0.0320.001
put14.502.416.403.8011.1300.000.00-0.983-0.0180.000
put15.002.916.904.6511.4680.001.00-0.984-0.0190.000
put15.503.457.405.0511.7810.001.00-0.985-0.0190.000
put16.003.907.905.9212.0810.002.00-0.985-0.0190.000
put16.504.408.405.8212.3693.007.00-0.986-0.0190.000
put17.004.908.906.2712.6424.005.00-0.987-0.0200.000
put17.505.409.406.9312.7231.002.00-0.987-0.0200.000
put18.005.909.907.4111.1361.002.00-0.987-0.0200.000
put18.506.409.358.259.3851.008.00-0.988-0.0200.000
put19.007.359.808.749.3860.0010.00-0.988-0.0200.000
put19.507.4011.409.0013.8440.003.00-0.989-0.0200.000
put20.007.9011.909.4514.0580.005.00-0.989-0.0210.000
put20.508.4012.409.7814.2640.000.00-0.989-0.0210.000
put21.008.9012.9510.2214.6441.000.00-0.989-0.0210.000
put22.009.9013.9511.2015.0240.000.00-0.990-0.0210.000
put23.0010.9014.9512.2615.3800.000.00-0.990-0.0210.000
put24.0011.9015.9513.1915.7150.000.00-0.991-0.0210.000
put25.0012.9017.050.0016.3960.000.00-0.991-0.0220.000
put26.0013.9017.950.0016.3330.000.00-0.991-0.0220.000

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-10SCHEDULE 13GSEC
2026-11-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-058-KCurrent report2026-11-05SEC
2026-10-298-KCurrent report2026-10-29SEC
2026-10-16SCHEDULE 13GSEC
2026-10-16SCHEDULE 13D/ASEC
2026-08-07SCHEDULE 13GSEC
2026-08-06S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-08-068-KCurrent report2026-08-06SEC
2026-08-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-06-234Statement of changes in beneficial ownership of securities2026-06-18SEC
2026-06-234Statement of changes in beneficial ownership of securities2026-06-18SEC
2026-06-234Statement of changes in beneficial ownership of securities2026-06-18SEC
2026-06-234Statement of changes in beneficial ownership of securities2026-06-18SEC
2026-06-234Statement of changes in beneficial ownership of securities2026-06-18SEC
2026-06-234Statement of changes in beneficial ownership of securities2026-06-18SEC
2026-06-234Statement of changes in beneficial ownership of securities2026-06-18SEC
2026-06-238-KCurrent report2026-06-18SEC
2026-05-27144Filing for proposed sale of securities under Rule 144.SEC
2026-05-15SCHEDULE 13D/ASEC
2026-05-07144Filing for proposed sale of securities under Rule 144.SEC
2026-05-068-KCurrent report2026-05-06SEC
2026-05-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-04-30SCHEDULE 13GSEC
2026-04-284Statement of changes in beneficial ownership of securities2026-04-25SEC
2026-04-27DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-04-27DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-06-18SEC
2026-04-27ARSAnnual report to security holders. 2025-12-31SEC
2026-04-27SCHEDULE 13G/ASEC
2026-04-164Statement of changes in beneficial ownership of securities2026-04-14SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
BlackRock, Inc.8.48%
SHAH CAPITAL MANAGEMENT7.38%
STATE STREET CORP7.14%
VANGUARD PORTFOLIO MANAGEMENT LLC4.63%
VANGUARD CAPITAL MANAGEMENT LLC4.41%
Sanofi4.17%
D. E. Shaw & Co., Inc.3.44%
GEODE CAPITAL MANAGEMENT, LLC2.56%
TWO SIGMA INVESTMENTS, LP2.49%
COATUE MANAGEMENT LLC2.33%

Funds

Fund% owned
State Street(R) SPDR(R) S&P(R) Biotech ETF4.58%
VANGUARD TOTAL STOCK MARKET INDEX FUND3.16%
iShares Russell 2000 ETF2.38%
VANGUARD SMALL-CAP INDEX FUND2.29%
VANGUARD SMALL-CAP GROWTH INDEX FUND1.32%
VANGUARD EXTENDED MARKET INDEX FUND1.15%
Fidelity Small Cap Index Fund1.01%
iShares Russell 2000 Value ETF0.87%
iShares Biotechnology ETF0.68%
PIMCO RAE US Small Fund0.62%

OakChart. NVAX. Cached 15 minutes.